日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The ATR inhibitor elimusertib exhibits anti-lymphoma activity and synergizes with the PI3K inhibitor copanlisib

ATR 抑制剂 elimusertib 具有抗淋巴瘤活性,并与 PI3K 抑制剂 copanlisib 产生协同作用

Giulio Sartori, Chiara Tarantelli, Filippo Spriano, Eugenio Gaudio, Luciano Cascione, Michele Mascia, Marilia Barreca, Alberto J Arribas, Luca Licenziato, Gaetanina Golino, Adele Ferragamo, Stefano Pileri, Giovanna Damia, Emanuele Zucca, Anastasios Stathis, Oliver Politz, Antje M Wengner, Francesco

Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance

靶向髓系趋化作用逆转前列腺癌治疗耐药性

Christina Guo #, Adam Sharp #, Bora Gurel, Mateus Crespo, Ines Figueiredo, Suneil Jain, Ursula Vogl, Jan Rekowski, Mahtab Rouhifard, Lewis Gallagher, Wei Yuan, Suzanne Carreira, Khobe Chandran, Alec Paschalis, Ilaria Colombo, Anastasios Stathis, Claudia Bertan, George Seed, Jane Goodall, Florence Ra

Pharmacologic screen identifies active combinations with BET inhibitors and LRRK2 as a novel putative target in lymphoma

药理学筛选确定 BET 抑制剂与 LRRK2 的活性组合是淋巴瘤的新靶点

Filippo Spriano, Giulio Sartori, Chiara Tarantelli, Marilia Barreca, Gaetanina Golino, Andrea Rinaldi, Sara Napoli, Michele Mascia, Lorenzo Scalise, Alberto J Arribas, Luciano Cascione, Emanuele Zucca, Anastasios Stathis, Eugenio Gaudio, Francesco Bertoni

Study of the antilymphoma activity of pracinostat reveals different sensitivities of DLBCL cells to HDAC inhibitors

pracinostat 抗淋巴瘤活性研究揭示 DLBCL 细胞对 HDAC 抑制剂的不同敏感性

Afua Adjeiwaa Mensah, Filippo Spriano, Giulio Sartori, Valdemar Priebe, Luciano Cascione, Eugenio Gaudio, Chiara Tarantelli, Elisa Civanelli, Luca Aresu, Andrea Rinaldi, Giovanna Damia, Emanuela Lovati, Emanuele Zucca, Anastasios Stathis, Claudio Pietra, Francesco Bertoni

The bromodomain and extra-terminal domain degrader MZ1 exhibits preclinical anti-tumoral activity in diffuse large B-cell lymphoma of the activated B cell-like type

溴结构域和末端域外降解剂 MZ1 在活化 B 细胞样类型的弥漫大 B 细胞淋巴瘤中表现出临床前抗肿瘤活性

Chiara Tarantelli, Eleonora Cannas, Hillarie Ekeh, Carmelo Moscatello, Eugenio Gaudio, Luciano Cascione, Sara Napoli, Cesare Rech, Andrea Testa, Chiara Maniaci, Andrea Rinaldi, Emanuele Zucca, Anastasios Stathis, Alessio Ciulli, Francesco Bertoni

Copanlisib synergizes with conventional and targeted agents including venetoclax in B- and T-cell lymphoma models

Copanlisib 在 B 细胞和 T 细胞淋巴瘤模型中与包括维奈克拉在内的传统和靶向药物具有协同作用

Chiara Tarantelli, Martin Lange, Eugenio Gaudio, Luciano Cascione, Filippo Spriano, Ivo Kwee, Alberto J Arribas, Andrea Rinaldi, Thibaud Jourdan, Melanie Berthold, Andrea Sturz, Carolyn Sperl, Francesco Margheriti, Lorenzo Scalise, Giuseppe Gritti, Davide Rossi, Anastasios Stathis, Ningshu Liu, Eman

Antitumor activity of the dual BET and CBP/EP300 inhibitor NEO2734

双重 BET 和 CBP/EP300 抑制剂 NEO2734 的抗肿瘤活性

Filippo Spriano, Eugenio Gaudio, Luciano Cascione, Chiara Tarantelli, Federica Melle, Giovanna Motta, Valdemar Priebe, Andrea Rinaldi, Gaetanina Golino, Afua Adjeiwaa Mensah, Luca Aresu, Emanuele Zucca, Stefano Pileri, Michael Witcher, Bill Brown, Claes Wahlestedt, Francis Giles, Anastasios Stathis,

Single and combined BTK and PI3Kδ inhibition with acalabrutinib and ACP-319 in pre-clinical models of aggressive lymphomas

在侵袭性淋巴瘤临床前模型中,使用阿卡替尼和 ACP-319 单独或联合抑制 BTK 和 PI3Kδ

Filippo Spriano, Chiara Tarantelli, Eugenio Gaudio, Magdalena M Gerlach, Valdemar Priebe, Luciano Cascione, Elena Bernasconi, Altea Targa, Michele Mascia, Stefan Dirnhofer, Anastasios Stathis, Emanuele Zucca, Francesco Bertoni

The Novel TORC1/2 Kinase Inhibitor PQR620 Has Anti-Tumor Activity in Lymphomas as a Single Agent and in Combination with Venetoclax

新型 TORC1/2 激酶抑制剂 PQR620 作为单一药物以及与 Venetoclax 联合使用,对淋巴瘤具有抗肿瘤活性

Chiara Tarantelli, Eugenio Gaudio, Petra Hillmann, Filippo Spriano, Giulio Sartori, Luca Aresu, Luciano Cascione, Denise Rageot, Ivo Kwee, Florent Beaufils, Emanuele Zucca, Anastasios Stathis, Matthias P Wymann, Vladimir Cmiljanovic, Doriano Fabbro, Francesco Bertoni

Preclinical evaluation of the BET bromodomain inhibitor BAY 1238097 for the treatment of lymphoma

BET 溴结构域抑制剂 BAY 1238097 治疗淋巴瘤的临床前评估

Elena Bernasconi, Eugenio Gaudio, Pascale Lejeune, Chiara Tarantelli, Luciano Cascione, Ivo Kwee, Filippo Spriano, Andrea Rinaldi, Afua A Mensah, Elaine Chung, Anastasios Stathis, Stephan Siegel, Norbert Schmees, Matthias Ocker, Emanuele Zucca, Bernard Haendler, Francesco Bertoni